David F. Hale

Filings by David F. Hale span 3 companies, the busiest being Dermata Therapeutics, Inc., Oncternal Therapeutics, Inc. and Biocept Inc. In total, 8 filings cover trades dated from 30 June 2021 to 23 January 2025.

On the open market, the record shows 1 purchase worth €5,962 and 2 sales worth €16k. The net balance comes to €10k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants.

The latest filing, published on 23 January 2025, reports a share grant in Dermata Therapeutics, Inc. The last purchase on record was published on 27 February 2024, which is 964 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.